Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TSH-TSHR axis promotes tumor immune evasion. | J Immunother Cancer | 2022 | 35101946 | PubTator, text mining | PubMed |
| Identification of four novel hub genes as monitoring biomarkers for colorectal cancer. | Hereditas | 2022 | 35093172 | PubTator, text mining | PubMed |
| Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway. | Cancer Cell Int | 2022 | 35081975 | PubTator, text mining | PubMed |
| CircRNA PRH1-PRR4 stimulates RAB3D to regulate the malignant progression of NSCLC by sponging miR-877-5p. | Thorac Cancer | 2022 | 35076987 | PubTator, text mining | PubMed |
| Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. | Mol Neurodegener | 2022 | 35073950 | PubTator, text mining | PubMed |
| Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. | Viruses | 2022 | 35062298 | PubTator, text mining | PubMed |
| CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space. | Int J Mol Sci | 2022 | 35054978 | PubTator, text mining | PubMed |
| Neuroinflammation: A Potential Risk for Dementia. | Int J Mol Sci | 2022 | 35054805 | PubTator, text mining | PubMed |
| Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity. | Clin Cancer Res | 2022 | 35046055 | PubTator, text mining | PubMed |
| Identifying the potential role of IL-1β in the molecular mechanisms of disc degeneration using gene expression profiling and bioinformatics analysis. | J Orthop Surg (Hong Kong) | 2022 | 35042389 | PubTator, text mining | PubMed |
| An integrative analysis of DNA methylation and transcriptome showed the dysfunction of MAPK pathway was involved in the damage of human chondrocyte induced by T-2 toxin. | BMC Mol Cell Biol | 2022 | 35038982 | PubTator, text mining | PubMed |
| Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium. | Bioengineered | 2022 | 35037831 | PubTator, text mining | PubMed |
| The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. | Cancer Manag Res | 2022 | 35018117 | PubTator, text mining | PubMed |
| Identification of the Key Immune-Related Genes in Chronic Obstructive Pulmonary Disease Based on Immune Infiltration Analysis. | Int J Chron Obstruct Pulmon Dis | 2022 | 35018096 | PubTator, text mining | PubMed |
| Transcriptional alterations in bladder epithelial cells in response to infection with different morphological states of uropathogenic Escherichia coli. | Sci Rep | 2022 | 35017565 | PubTator, text mining | PubMed |
| Molecular changes in adipocyte-derived stem cells during their interplay with cervical cancer cells. | Cell Oncol (Dordr) | 2022 | 35013999 | PubTator, text mining | PubMed |
| Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. | Nat Commun | 2022 | 35013146 | PubTator, text mining | PubMed |
| Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion. | Cancer Biol Ther | 2022 | 35000525 | PubTator, text mining | PubMed |
| In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling. | Gene | 2022 | 34995734 | PubTator, text mining | PubMed |
| The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. | Gastroenterology | 2022 | 34995532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=65